Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 25, 2015American Journal of HematologyOpen Access

Increased bone marrow FDG uptake at PET/CT is not a sufficient proof of bone marrow involvement in diffuse large B‐cell lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

HAHugo J.A. AdamsTKThomas C. Kwee

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Adams et al. (2015) studied this question.

synapsesocial.com/papers/6a7b1ef714b028facf0eb0f7https://doi.org/10.1002/ajh.24061
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Impact of Concordant and Discordant Bone Marrow Involvement on Outcome in Diffuse Large B-Cell Lymphoma Treated With R-CHOP2011 · 233 citations
  2. 2PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement2013 · 246 citations
  3. 3Combined PET and Biopsy Evidence of Marrow Involvement Improves Prognostic Prediction in Diffuse Large B-Cell Lymphoma2014 · 76 citations
  4. 4Heterogeneous bone marrow uptake on interim 18F-fluorodeoxyglucose positron emission tomography for lymphoma mimicking disease progression: a case report2014 · 3 citations
  5. 5FDG PET of Primary Benign and Malignant Bone Tumors: Standardized Uptake Value in 52 Lesions2001 · 318 citations